Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Ina-Maria Harwerth
Introduction
Ina-Maria Harwerth is a notable inventor based in Grenzach-Wyhlen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. Her work has implications for the diagnosis and treatment of tumors, showcasing her commitment to advancing medical science.
Latest Patents
Ina-Maria Harwerth holds a patent for "Recombinant antibodies specific for a growth factor receptor." This invention involves recombinant antibodies directed to the extracellular domain of the human growth factor receptor c-erbB-2. The patent encompasses a light chain variable domain and a heavy chain variable domain of a monoclonal antibody, as well as methods for manufacturing these antibodies. Additionally, it includes hybridoma cells that secrete the monoclonal antibodies, DNA coding for the variable domains, and host cells transformed with this DNA. The use of these recombinant antibodies and monoclonal antibodies is aimed at improving tumor diagnosis and treatment.
Career Highlights
Ina-Maria Harwerth is currently associated with Novartis Corporation, a leading global healthcare company. Her role at Novartis allows her to collaborate with other experts in the field, further enhancing her contributions to biotechnology and medicine.
Collaborations
Throughout her career, Ina-Maria has worked alongside esteemed colleagues such as Winfried Stephan Wels and Nancy E Hynes. These collaborations have enriched her research and have been instrumental in the development of innovative solutions in her field.
Conclusion
Ina-Maria Harwerth's work exemplifies the impact of innovation in biotechnology. Her patent on recombinant antibodies represents a significant advancement in the fight against tumors, highlighting her role as a key contributor to medical research.